Insider · CIK 0001971400
Matthew Winton
Files at CRVO (CervoMed Inc.), INZY (Inozyme Pharma, Inc.). First filing Nov 17, 2025, latest Nov 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRVO: CervoMed Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | CervoMed Inc. | $41k 5,000 shares | +50% | - | |
| 46Moderate | CervoMed Inc. | $76k 10,000 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Feb 13, 2026 |
| Nov 17, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +3,500 | $8.43 | $30k | 13,500 | Nov 19, 2025 |
| Nov 18, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +1,500 | $7.95 | $12k | 15,000 | Nov 19, 2025 |
| Nov 14, 2025 | CRVO CervoMed Inc. | POpen-market purchase Common Stock | +10,000 | $7.57 | $76k | 10,000 | Nov 17, 2025 |
| Oct 6, 2025 | CRVO CervoMed Inc. | AGrant or award Stock Option (Right to Buy)derivative | +75,000 | $0.00 | $0 | 75,000 | Oct 8, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | UTender of shares Common Stock | -21,743 | $4.00 | $87k | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -41,500 | - | - | 0 | Jul 3, 2025 |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -145,000 | - | - | 0 | Jul 3, 2025 |
| Jun 25, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Common Stock | +14,355 | $0.74 | $11k | 21,743 | Jun 27, 2025 |
| Mar 31, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Common Stock | +2,490 | $0.77 | $1,917 | 7,388 | Apr 2, 2025 |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +145,000 | $0.00 | $0 | 145,000 | Mar 17, 2025 |
| Mar 11, 2025 | INZY Inozyme Pharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +41,500 | $0.00 | $0 | 41,500 | Mar 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.